Episode Details

Send us Fan Mail

A scan that can’t wait sounds like science fiction until you hear the numbers: carbon-11 has a 12-minute half-life, which means a carbon-11 methionine PET scan has to be made onsite, injected fast, and run immediately or the signal can vanish. That time pressure is exactly why we traveled to Japan to talk with Dr. Toshihiko Sato at the Utsunomiya Clinic, where they produce specialized PET radiotracers and perform total-body methionine PET imaging that many hospitals simply can’t offer. 

We get into what methionine PET shows that a standard FDG PET (glucose PET) may miss, and why “we think” isn’t good enough when you’re trying to confirm whether cancer is truly gone. We also talk through the practical reality of running these scans, from the onsite cyclotron to the tight workflow that keeps results reliable, plus how other tracers differ in half-life and use cases across neurology and oncology. 

Then we zoom out to the bigger theme: metabolic cancer therapy as an add-on to standard care. We share how methionine restriction, methioninase, and carefully chosen combinations with chemotherapy, radiotherapy, and immunotherapy can change outcomes, including our own stage IV story that leads to complete remission verified by imaging. If you’ve ever wondered whether nutrition, metabolism, and precision diagnostics belong in the same treatment plan, this conversation will give you new questions to ask. 

If this helped you, subscribe, share it with someone navigating cancer decisions, and leave a review so more people can find these tools and discussions.

Intro for podcast

Support the show

Support for Joe's Cure

Here is the link for Sunday's 4 pm Pacific time Zoom meeting